【合作终止后减肥药后续供应成关键 大摩给予予Hims & Hers Health(HIMS.US)“与大盘持平”评级】智

智通财经
Jul 01, 2025
【合作终止后减肥药后续供应成关键 大摩给予予Hims & Hers Health(HIMS.US)“与大盘持平”评级】智通财经APP获悉,在诺和诺德(NVO.US)终止与远程医疗公司Hims & Hers Health合作后,摩根士丹利发布研报给予Hims & Hers Health(HIMS.US)“与大盘持平”评级,最新目标价40美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10